PLOD3 is overexpressed in HCC (Elsemman et al., 2016; Shen et al., 2018) and is a potential diagnosis marker for early-stage HCC (Shen et al., 2018). This evidence concerns the gene PLOD3 and hepatocellular carcinoma.